Emcure Pharmaceuticals Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
25648.06 Cr.
|
P/BV
|
6.23
|
Book Value (Rs.)
|
217.34
|
52 Week High/Low (Rs.)
|
1580/889
|
FV/ML
|
10/1
|
P/E(X)
|
37.64
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
35.95
|
Div Yield (%)
|
0.22
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
No. of Equity Shares (in Lacs) | 1894.83 | 1811.52 | 1808.52 | 1808.52 |
| | | | |
EQUITIES AND LIABILITIES | | | | |
SHAREHOLDER'S FUNDS | | | | |
Equity Share Capital | 189.48 | 181.15 | 180.85 | 180.85 |
Total Share Capital | 189.48 | 181.15 | 180.85 | 180.85 |
| | | | |
Reserves and Surplus | 4256.70 | 2771.13 | 2320.27 | 1806.70 |
Total Reserves and Surplus | 4256.70 | 2771.13 | 2320.27 | 1806.70 |
Total Shareholders Funds | 4446.19 | 2952.28 | 2501.13 | 1987.55 |
Minority Interest | 195.37 | 169.48 | 148.53 | 126.59 |
| | | | |
NON-CURRENT LIABILITIES | | | | |
Long Term Borrowings | 189.94 | 766.60 | 744.14 | 717.28 |
Deferred Tax Liabilities [Net] | 120.03 | 137.42 | 38.90 | 42.61 |
Other Long Term Liabilities | 565.35 | 526.59 | 180.98 | 182.50 |
Long Term Provisions | 47.58 | 43.32 | 39.67 | 42.11 |
Total Non-Current Liabilities | 922.90 | 1473.93 | 1003.68 | 984.50 |
| | | | |
CURRENT LIABILITIES | | | | |
Short Term Borrowings | 541.77 | 1320.72 | 1450.80 | 1366.35 |
Trade Payables | 1479.58 | 1309.37 | 1086.11 | 1125.19 |
Other Current Liabilities | 592.41 | 534.66 | 442.19 | 429.43 |
Short Term Provisions | 54.51 | 45.74 | 40.09 | 43.86 |
Total Current Liabilities | 2668.27 | 3210.47 | 3019.19 | 2964.83 |
| | | | |
Total Capital And Liabilities | 8232.72 | 7806.16 | 6672.53 | 6063.47 |
| | | | |
ASSETS | | | | |
NON-CURRENT ASSETS | | | | |
Tangible Assets | 2303.06 | 2264.86 | 1811.23 | 1675.65 |
Intangible Assets | 525.90 | 481.00 | 117.93 | 151.26 |
Capital Work-In-Progress | 124.06 | 132.35 | 403.53 | 309.80 |
Intangible Assets Under Development | 53.34 | 26.77 | 7.88 | 10.10 |
Fixed Assets | 3006.36 | 2904.98 | 2340.57 | 2146.82 |
Goodwill On Consolidation | 367.78 | 378.69 | 217.74 | 217.40 |
Non-Current Investments | 19.34 | 18.42 | 25.00 | 25.00 |
Deferred Tax Assets [Net] | 110.99 | 96.80 | 99.13 | 116.08 |
Other Non-Current Assets | 172.40 | 147.37 | 154.19 | 134.08 |
Total Non-Current Assets | 3676.86 | 3546.25 | 2836.62 | 2639.37 |
| | | | |
| | | | |
CURRENT ASSETS | | | | |
Current Investments | 76.04 | 299.65 | 0.00 | 0.00 |
Inventories | 1931.81 | 1525.10 | 1383.03 | 1449.42 |
Trade Receivables | 2002.24 | 1858.81 | 1648.30 | 1308.51 |
Cash And Cash Equivalents | 165.30 | 232.41 | 458.26 | 313.30 |
OtherCurrentAssets | 380.47 | 343.95 | 346.33 | 352.88 |
Total Current Assets | 4555.86 | 4259.92 | 3835.91 | 3424.10 |
| | | | |
Total Assets | 8232.72 | 7806.16 | 6672.53 | 6063.47 |
| | | | |
OTHER INFORMATION | | | | |
| | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | |
Contingent Liabilities | 474.42 | 378.81 | 176.53 | 138.72 |
| | | | |
NON-CURRENT INVESTMENTS | | | | |
Non-Current Investments Unquoted Book Value | 33.66 | 25.00 | 25.00 | 25.00 |
| | | | |
CURRENT INVESTMENTS | | | | |
Current Investments Quoted Market Value | 76.04 | 39.22 | 0.00 | 0.00 |
Current Investments Unquoted Book Value | 0.00 | 250.00 | 0.00 | 0.00 |